3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
9
Lung Neoplasms
5
Myeloproliferative Disorders
4
Leukemia, Myelomonocytic, Chronic
4
Sarcoma
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Stomatitis
2
Primary Myelofibrosis
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Mucositis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Monocytic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Prostate Cancer Metastatic
1
Polycythemia Vera
1
Interventions
Magnetic Resonance Spectroscopy
5
lenvatinib
3
cabozantinib
3
Sunitinib
3
Iodine-131
3
trametinib
2
Fluorodeoxyglucose F18
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
vandetanib
1
tremelimumab
1
tanespimycin
1
romidepsin
1
pembrolizumab
1
omipalisib
1
durvalumab
1
dabrafenib
1
cediranib
1
aflibercept
1
Vorinostat
1
Thyrotropin Alfa
1
Specimen Handling
1
Sorafenib
1
Pharmacogenomic Testing
1
Nivolumab
1
Lenalidomide
1
Ipilimumab
1
Iodine-124
1
Gefitinib
1
Decitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Follicular
×
Injections
×
Clear all
No trials found.